Bangladesh
· Delayed Price · Currency is BDT Orion Infusion Statistics
Total Valuation
Orion Infusion has a market cap or net worth of BDT 9.36 billion. The enterprise value is 9.65 billion.
| Market Cap | 9.36B |
| Enterprise Value | 9.65B |
Important Dates
The next estimated earnings date is Tuesday, November 4, 2025.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | Dec 5, 2024 |
Share Statistics
Orion Infusion has 20.36 million shares outstanding.
| Current Share Class | 20.36M |
| Shares Outstanding | 20.36M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.27% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 227.14.
| PE Ratio | 227.14 |
| Forward PE | n/a |
| PS Ratio | 13.87 |
| PB Ratio | 29.27 |
| P/TBV Ratio | 29.27 |
| P/FCF Ratio | 5,474.70 |
| P/OCF Ratio | 3,795.86 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 97.03, with an EV/FCF ratio of 5,642.27.
| EV / Earnings | 234.09 |
| EV / Sales | 14.29 |
| EV / EBITDA | 97.03 |
| EV / EBIT | 114.99 |
| EV / FCF | 5,642.27 |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.99.
| Current Ratio | 0.93 |
| Quick Ratio | 0.28 |
| Debt / Equity | 0.99 |
| Debt / EBITDA | 3.19 |
| Debt / FCF | 185.47 |
| Interest Coverage | 2.35 |
Financial Efficiency
Return on equity (ROE) is 13.22% and return on invested capital (ROIC) is 8.47%.
| Return on Equity (ROE) | 13.22% |
| Return on Assets (ROA) | 6.34% |
| Return on Invested Capital (ROIC) | 8.47% |
| Return on Capital Employed (ROCE) | 24.08% |
| Revenue Per Employee | 940,229 |
| Profits Per Employee | 57,415 |
| Employee Count | 718 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 2.77 |
Taxes
In the past 12 months, Orion Infusion has paid 7.18 million in taxes.
| Income Tax | 7.18M |
| Effective Tax Rate | 14.83% |
Stock Price Statistics
The stock price has increased by +1.86% in the last 52 weeks. The beta is -2.46, so Orion Infusion's price volatility has been lower than the market average.
| Beta (5Y) | -2.46 |
| 52-Week Price Change | +1.86% |
| 50-Day Moving Average | 340.86 |
| 200-Day Moving Average | 353.11 |
| Relative Strength Index (RSI) | 83.58 |
| Average Volume (20 Days) | 414,281 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Orion Infusion had revenue of BDT 675.08 million and earned 41.22 million in profits. Earnings per share was 2.02.
| Revenue | 675.08M |
| Gross Profit | 284.27M |
| Operating Income | 83.92M |
| Pretax Income | 48.40M |
| Net Income | 41.22M |
| EBITDA | 92.33M |
| EBIT | 83.92M |
| Earnings Per Share (EPS) | 2.02 |
Balance Sheet
The company has 23.69 million in cash and 317.21 million in debt, giving a net cash position of -286.60 million or -14.08 per share.
| Cash & Cash Equivalents | 23.69M |
| Total Debt | 317.21M |
| Net Cash | -286.60M |
| Net Cash Per Share | -14.08 |
| Equity (Book Value) | 319.93M |
| Book Value Per Share | 15.71 |
| Working Capital | -35.80M |
Cash Flow
In the last 12 months, operating cash flow was 2.47 million and capital expenditures -756,437, giving a free cash flow of 1.71 million.
| Operating Cash Flow | 2.47M |
| Capital Expenditures | -756,437 |
| Free Cash Flow | 1.71M |
| FCF Per Share | 0.08 |
Margins
Gross margin is 42.11%, with operating and profit margins of 12.43% and 6.11%.
| Gross Margin | 42.11% |
| Operating Margin | 12.43% |
| Pretax Margin | 7.17% |
| Profit Margin | 6.11% |
| EBITDA Margin | 13.68% |
| EBIT Margin | 12.43% |
| FCF Margin | 0.25% |
Dividends & Yields
This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 0.26%.
| Dividend Per Share | 1.20 |
| Dividend Yield | 0.26% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 16.79% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.26% |
| Earnings Yield | 0.44% |
| FCF Yield | 0.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.
| Last Split Date | Dec 4, 2011 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
Orion Infusion has an Altman Z-Score of 10.47 and a Piotroski F-Score of 5.
| Altman Z-Score | 10.47 |
| Piotroski F-Score | 5 |